VCM Analyzer VCM viscoelastic coagulation monitor demonstrated the utility of advanced coagulation monitoring in prolonged field care settings. Entegrion is extremely proud to offer the VCM in the support of remote trauma patients as we have supported hospitals around the world.” — John B. Mowell, Executive Chairman of Entegrion. DURHAM, NORTH CAROLINA, USA, April 15, 2021 /EINPresswire.com/ -- Entegrion, Inc., a leading developer of innovative solutions for clinical diagnosis and management of hemostasis, today announced the acceptance of two abstracts demonstrating utility of the VCMviscoelastic coagulation monitor for use in prolonged field care settings and out-of-hospital evaluation of coagulation status, for presentation at the European Chapter of Extracorporeal Life Support Organization (Euro-ELSO) virtual meeting in May 2021. Both abstracts will be published in the peer-reviewed scholarly journal Perfusion (SAGE Journals, ISSN: 0267-6591 [print]; 1477-111X [web]). The work was performed as a part of an ongoing collaboration with the Autonomous Reanimation and Evacuation Research Program (AREVA)/Geneva Foundation Laboratory at Brooks City Base in San Antonio, TX. Both abstracts looked at the use of the VCM as an assessment device in prolonged field care settings. In the continued work of improving trauma outcomes, there has been increased visibility to the negative implications coagulopathy has on survivability. Many trauma patients are at risk of blood clotting or bleeding events. Traditional coagulation testing of hemostasis and thrombosis may not be reflective of the actual mechanisms of thrombosis. A better method for real-time evaluation of these patients is viscoelastic testing. The VCM allows for the monitoring of the entire coagulation cascade at the patient side without the use of highly complex or expensive alternatives. The AREVA research team emphasized that comprehensive point-of-care devices to assess coagulation status in the out-of-hospital setting are currently severely limited. Coagulation tools like VCM are essential for applications of coagulation status in remote environments. For the first time, the VCM makes this valuable diagnostic adjunct available to the broad range of critical care sites supporting trauma patients, allowing for an improvement in patient care and greater understanding of patients’ hemostatic conditions. Viscoelastic testing has proven invaluable in the monitoring and treatment of trauma patients in Intensive Care Units, Emergency Departments, and extended care facilities. The VCM now makes this valuable diagnostic tool available in the field.